Scientific Research
This page is in a'blog' format with the latest scientific PSC research identified by Google Scholar, Readbyqmx.com and other sources added regularly.

David Al Dulaimi
Department of Gastroenterology, Alexandra Hospital, Redditch, UK 

This link will take you to a number of synopsis of recent papers considering the advances of knowledge in inflammatory bowel disease.

​Papers were prepared by:
Drs Luke Materacki and Ishfaq Ahmad, Alexandra Hospital, UK

Gastroenterol Hepatol Bed Bench 2014;8(4):313-315 

Journal of Gastroenterology and HepatologySpecial Issue

Abstracts of Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 | World Congress of Gastroenterology, Brisbane, Queensland, Australia 28 September-2 October 2015

Abstracts include:

• Outcomes post-liver transplant for primary sclerosing cholangitis: colitis activity and malignancy
• Colonic ultrasound in inflammatory bowel disease: an accurate marker of disease activity and mucosal healing
• The evolution of indications and outcomes of surgery for patients with Crohn's disease during the biological agent era
• Inflammatory bowel disease: a statewide incidence and prevalence study in Tasmania, Australia​

Please click here to view these and further abstracts: 

Volume 30,  Issue Supplement S3, pages 117–148, September 2015

INTRODUCTION

Patients with ulcerative colitis or Crohn’s colitis have an increased risk of colorectal cancer (CRC). Most cases are believed to arise from dysplasia, and surveillance colonos- copy therefore is recommended to detect dysplasia. Detec- tion of dysplasia traditionally has relied on both examination of the mucosa with targeted biopsies of visible lesions and extensive random biopsies to identify invisible dysplasia ... Please click here to read the full text version of this consensus statement.

Gastrointestinal Endoscopy, 2015, 81 (3)
Copyright a 2015 by the American Society for Gastrointestinal Endoscopy and American Gastroenterological Association
http://dx.doi.org/10.1016/j.gie.2014.12.009 ​

Update on inflammatory bowel disease in patients with primary sclerosing cholangitis

Christos Tsaitas, Anysia Semertzidou and Emmanouil Sinakos. World J Hepatol. 2014 April 27; 6(4): 1780-187. Published online 2014 April 27. doi: 10.4254/wjh.v6.i4.178.

Abstract

Patients with primary sclerosing cholangitis (PSC) complicated by inflammatory bowel disease (IBD) represent a distinct subset of patients with unique characteristics, which have serious clinical implications. The aim of this literature review was to shed light to the obscure clinical and molecular aspects of the two diseases combined utilizing current data available and putting issues of diagnosis and treatment into perspective. The prevalence of IBD, mainly ulcerative colitis in PSC patients is estimated to be 21%-80%, dependent on screening programs and nationality . . .  Please click here to read further